Microbiota-derived genotoxin tilimycin generates colonic stem cell mutations.

[1]  J. Crawford,et al.  Commensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolites , 2022, Science.

[2]  C. Sears,et al.  Microbial metabolites damage DNA , 2022, Science.

[3]  G. Raber,et al.  Enterotoxin tilimycin from gut-resident Klebsiella promotes mutational evolution and antibiotic resistance in mice , 2022, Nature Microbiology.

[4]  F. Turroni,et al.  Gut microbe metabolism of small molecules supports human development across the early stages of life , 2022, Frontiers in Microbiology.

[5]  Edoardo Pasolli,et al.  Extending and improving metagenomic taxonomic profiling with uncharacterized species using MetaPhlAn 4 , 2022, bioRxiv.

[6]  Heping Zhang,et al.  Probiotics synergized with conventional regimen in managing Parkinson’s disease , 2022, NPJ Parkinson's disease.

[7]  K. Holt,et al.  Epidemiology and genomic analysis of Klebsiella oxytoca from a single hospital network in Australia , 2022, BMC Infectious Diseases.

[8]  P. Dempsey,et al.  Injury-Induced Cellular Plasticity Drives Intestinal Regeneration , 2021, Cellular and molecular gastroenterology and hepatology.

[9]  E. Leitner,et al.  Toxin-Producing Klebsiella oxytoca in Healthy Infants: Commensal or Pathobiont? , 2021, Journal of pediatric gastroenterology and nutrition.

[10]  E. Leitner,et al.  Variation in Accessory Genes Within the Klebsiella oxytoca Species Complex Delineates Monophyletic Members and Simplifies Coherent Genotyping , 2021, Frontiers in Microbiology.

[11]  G. Raber,et al.  Simultaneous quantification of enterotoxins tilimycin and tilivalline in biological matrices using HPLC high resolution ESMS2 based on isotopically 15N-labeled internal standards. , 2021, Talanta.

[12]  L. Hall,et al.  Improved molecular characterization of the Klebsiella oxytoca complex reveals the prevalence of the kleboxymycin biosynthetic gene cluster , 2020, Microbial genomics.

[13]  V. Guidolin,et al.  Biosynthesis, Mechanism of Action, and Inhibition of the Enterotoxin Tilimycin Produced by the Opportunistic Pathogen Klebsiella oxytoca. , 2020, ACS infectious diseases.

[14]  P. Steinberg,et al.  Mode of action-based risk assessment of genotoxic carcinogens , 2020, Archives of Toxicology.

[15]  Britta A. M. Bouwman,et al.  Colibactin DNA-damage signature indicates mutational impact in colorectal cancer , 2020, Nature Medicine.

[16]  J. Shupe,et al.  Clostridioides difficile infection damages colonic stem cells via TcdB, impairing epithelial repair and recovery from disease , 2020, Proceedings of the National Academy of Sciences.

[17]  P. Huber.  Targeting of the apical junctional complex by bacterial pathogens. , 2020, Biochimica et biophysica acta. Biomembranes.

[18]  A. Need,et al.  Mutational signature in colorectal cancer caused by genotoxic pks+E. coli , 2020, Nature.

[19]  Yanjiao Zhou,et al.  Cytotoxin-producing Klebsiella oxytoca in the preterm gut and its association with necrotizing enterocolitis , 2020, Emerging microbes & infections.

[20]  Kevin Vervier,et al.  Stunted microbiota and opportunistic pathogen colonisation in caesarean section birth , 2019, Nature.

[21]  A. Amiot,et al.  Crypt- and Mucosa-Associated Core Microbiotas in Humans and Their Alteration in Colon Cancer Patients , 2019, mBio.

[22]  I. Barasoain,et al.  Klebsiella oxytoca enterotoxins tilimycin and tilivalline have distinct host DNA-damaging and microtubule-stabilizing activities , 2019, Proceedings of the National Academy of Sciences.

[23]  M. Stratton,et al.  The landscape of somatic mutation in normal colorectal epithelial cells , 2018, Nature.

[24]  R. Müller,et al.  Biosynthesis of the Klebsiella oxytoca Pathogenicity Factor Tilivalline: Heterologous Expression, in Vitro Biosynthesis, and Inhibitor Development. , 2018, ACS chemical biology.

[25]  Curtis Huttenhower,et al.  bioBakery: a meta’omic analysis environment , 2017, Bioinform..

[26]  K. Zangger,et al.  Biosynthesis of the Enterotoxic Pyrrolobenzodiazepine Natural Product Tilivalline , 2017, Angewandte Chemie.

[27]  W. Chan,et al.  A tricyclic pyrrolobenzodiazepine produced by Klebsiella oxytoca is associated with cytotoxicity in antibiotic-associated hemorrhagic colitis , 2017, The Journal of Biological Chemistry.

[28]  C. Tropini,et al.  The Gut Microbiome: Connecting Spatial Organization to Function. , 2017, Cell host & microbe.

[29]  Olivia I. Koues,et al.  The Colonic Crypt Protects Stem Cells from Microbiota-Derived Metabolites , 2016, Cell.

[30]  J. Ravel,et al.  Uncovering effects of antibiotics on the host and microbiota using transkingdom gene networks , 2015, Gut.

[31]  H. Weber,et al.  Enterotoxicity of a nonribosomal peptide causes antibiotic-associated colitis , 2014, Proceedings of the National Academy of Sciences.

[32]  Justin Zobel,et al.  SRST2: Rapid genomic surveillance for public health and hospital microbiology labs , 2014, bioRxiv.

[33]  E. Leitner,et al.  Genotypes of Klebsiella oxytoca Isolates from Patients with Nosocomial Pneumonia Are Distinct from Those of Isolates from Patients with Antibiotic-Associated Hemorrhagic Colitis , 2014, Journal of Clinical Microbiology.

[34]  J. Collins,et al.  Bactericidal Antibiotics Induce Mitochondrial Dysfunction and Oxidative Damage in Mammalian Cells , 2013, Science Translational Medicine.

[35]  P. Sansonetti,et al.  A Crypt-Specific Core Microbiota Resides in the Mouse Colon , 2012, mBio.

[36]  S. Mazmanian,et al.  A pathobiont of the microbiota balances host colonization and intestinal inflammation. , 2010, Cell host & microbe.

[37]  Hans Clevers,et al.  OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells. , 2009, Gastroenterology.

[38]  H. Clevers,et al.  Single Lgr5 stem cells build crypt–villus structures in vitro without a mesenchymal niche , 2009, Nature.

[39]  Hans Clevers,et al.  Transcription Factor Achaete Scute-Like 2 Controls Intestinal Stem Cell Fate , 2009, Cell.

[40]  H. Clevers,et al.  Stem cells, self-renewal, and differentiation in the intestinal epithelium. , 2009, Annual review of physiology.

[41]  D. Skibinski,et al.  Non-linear dose-response of DNA-reactive genotoxins: recommendations for data analysis. , 2009, Mutation research.

[42]  Caixia Ma,et al.  Modulation of Intestinal Goblet Cell Function during Infection by an Attaching and Effacing Bacterial Pathogen , 2007, Infection and Immunity.

[43]  H. Clevers,et al.  Identification of stem cells in small intestine and colon by marker gene Lgr5 , 2007, Nature.

[44]  Markus F Neurath,et al.  An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression , 2007, Nature Protocols.

[45]  G. Jenkins,et al.  Mechanistic influences for mutation induction curves after exposure to DNA-reactive carcinogens. , 2007, Cancer research.

[46]  C. Langner,et al.  Klebsiella oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis. , 2006, The New England journal of medicine.

[47]  W. Bodmer,et al.  Bottom-up histogenesis of colorectal adenomas: origin in the monocryptal adenoma and initial expansion by crypt fission. , 2003, Cancer research.

[48]  G. Thomas,et al.  Differences in susceptibility to colonic stem cell somatic mutation in three strains of mice , 2001, The Journal of pathology.

[49]  A. Öst,et al.  A reproducible grading scale for histological assessment of inflammation in ulcerative colitis , 2000, Gut.

[50]  J. Gordon,et al.  Notes from some crypt watchers: regulation of renewal in the mouse intestinal epithelium. , 1998, Current opinion in cell biology.

[51]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[52]  T. Chida,et al.  Cytotoxic Component(s) of Klebsiella oxytoca on HEp‐2 Cells , 1990, Microbiology and immunology.

[53]  G. Williams,et al.  Demonstration of somatic mutation and colonic crypt clonality by X-linked enzyme histochemistry , 1988, Nature.

[54]  JoVE Video Dataset , 2022 .